BioHarvest Sciences Inc. Files December 2024 6-K Report

Ticker: BHST · Form: 6-K · Filed: Dec 11, 2024

Sentiment: neutral

Topics: regulatory-filing, foreign-private-issuer

TL;DR

BIOHARVEST SCIENCES INC. (BHSC) filed its monthly 6-K report on 12/11/24, confirming its status as a foreign private issuer.

AI Summary

BioHarvest Sciences Inc. filed a Form 6-K on December 11, 2024, reporting for the month of December 2024. The company, previously known as Midnight Star Ventures Corp. and Canna-V-Cell Sciences Inc., is incorporated in A1 and has its principal executive offices in Vancouver, British Columbia, Canada. This filing is a report of a foreign private issuer.

Why It Matters

This filing provides an update on BioHarvest Sciences Inc.'s reporting status as a foreign private issuer, which is important for investors tracking the company's regulatory compliance and disclosures.

Risk Assessment

Risk Level: low — This filing is a routine report of a foreign private issuer and does not contain significant new financial or operational information that would inherently increase risk.

Key Players & Entities

FAQ

What is the purpose of this Form 6-K filing?

This Form 6-K is a Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934, for the month of December 2024.

What are the former names of BioHarvest Sciences Inc.?

BioHarvest Sciences Inc. was formerly known as Canna-V-Cell Sciences Inc. (name change effective October 8, 2019) and Midnight Star Ventures Corp. (name change effective November 21, 2017).

Where are BioHarvest Sciences Inc.'s principal executive offices located?

The principal executive offices are located at 1140-625 Howe Street, Vancouver, British Columbia V6C 2T6, Canada.

Does BioHarvest Sciences Inc. file annual reports under Form 20-F or Form 40-F?

The company indicates it files annual reports under cover of Form 20-F.

What is the SIC code for BioHarvest Sciences Inc.?

The Standard Industrial Classification (SIC) code for BioHarvest Sciences Inc. is 2834, which corresponds to Pharmaceutical Preparations.

Filing Stats: 204 words · 1 min read · ~1 pages · Grade level 18 · Accepted 2024-12-11 14:17:36

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. BIOHARVEST SCIENCES INC. (Registrant) Date: December 11, 2024 /s/ David Ryan Name: David Ryan Title: Vice-President, Investor Relations & Secretary

View on Read The Filing